秘鲁死亡原因的自动编码和选择:一项描述性研究,2016-2019年
Javier Vargas-Herrera1, Janet Miki2, Liliana López Wong3
1Universidad Nacional Mayor de San Marcos, Unidad de Telesalud, Lima, Peru.
概括
在秘鲁,用于自动选择潜在死亡原因的软件表现良好,从2016年的69.6%增加到2019年的78.8%. 这种改善与电子死亡证明的使用增加有关.
科学领域:
- 公共卫生 公共卫生
- 医疗信息学 医疗信息学
- 医学统计 医学统计
背景情况:
- 准确的死亡原因 (COD) 信息对于公共卫生监测和政策至关重要.
- 手动编码COD可能耗时,容易出现错误,影响数据的及时性和质量.
- 自动化软件提供了一个潜在的解决方案,以提高COD选择的效率和准确性.
研究的目的:
- 评估软件在自动选择秘鲁死亡的根本原因的性能.
- 分析2016年至2019年间软件性能趋势.
- 调查使用的死亡证明类型与软件性能之间的相关性.
主要方法:
- 描述性研究分析了来自秘鲁的446,217份死亡证明 (2016-2019).
- 趋势的奇平方测试用于评估软件性能随时间变化的变化.
- 相关性分析 (系数和R平方) 检查了电子死亡证明和软件性能之间的关系.
主要成果:
- 软件在自动选择潜在死亡原因方面的性能从2016年的69.6%显著增加到2019年的78.8% (p<0.001).
- 在使用电子死亡证明和软件性能之间观察到强烈的直接线性相关性 (相关系数 = 0.95;R2 = 0.89).
- 该研究强调了数字死亡证明对自动化COD选择准确性的积极影响.
结论:
- 该软件在自动选择潜在死亡原因方面表现良好并不断提高性能.
- 电子死亡证明的日益普及与软件性能的提高直接相关.
- 建议南美国家对医学术语词典进行进一步分析,以提高COD数据的标准化和可比性.
相关概念视频
01:08Prevalence and Incidence
621
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
621
01:25Statistical Methods for Analyzing Epidemiological Data
403
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
403
01:21Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
01:20Actuarial Approach
96
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96
01:09Censoring Survival Data
125
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
125
01:20Comparing the Survival Analysis of Two or More Groups
220
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
220